UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 1, 2016
THE COOPER COMPANIES, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 1-8597 | 94-2657368 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588
(Address of principal executive offices)
(925) 460-3600
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Election of Directors
On March 31, 2016, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors (the “Board”) of The Cooper Companies, Inc. (the “Company” or “Cooper”) voted to expand the size of the Board from 7 directors to 9 directors with effect from April 1, 2016 and to elect Colleen E. Jay and William A. Kozy to fill the new director positions, with effect from April 1, 2016, until their successors are duly elected and qualified or their earlier resignation or removal.
Both Ms. Jay and Mr. Kozy have both been determined to be independent directors under New York Stock Exchange listing standards. There are no arrangements or understandings between either Ms. Jay or Mr. Kozy and any other persons pursuant to which they were selected as directors. Additionally, there are no transactions involving the Company and either Ms. Jay or Mr. Kozy that the Company would be required to report pursuant to Item 404(a) of Regulation S-K.
Both Ms. Jay and Mr. Kozy will be compensated for their service as directors consistent with the compensation provided to other non-employee directors as described in the Company’s most recent proxy statement, filed with the Securities and Exchange Commission on January 29, 2016.
Concurrent with their election, Ms. Jay was appointed to the Organization & Compensation Committee and Mr. Kozy was appointed to the Audit and the Science & Technology Committees.
On April 4, 2016, Cooper issued a press release announcing the election of Ms. Jay and Mr. Kozy to the Board, a copy of which is attached hereto as Exhibit 99.1
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits:
| Exhibit |
Description | |
| 99.1 | Press Release dated April 4, 2016 issued by The Cooper Companies, Inc. | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE COOPER COMPANIES, INC. | ||
| By | /s Carol R. Kaufman | |
| Carol R. Kaufman | ||
| Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | ||
Dated: April 4, 2016
INDEX TO EXHIBITS
| Exhibit |
Description | |
| 99.1 | Press Release dated April 4, 2016 issued by The Cooper Companies, Inc. | |
Exhibit 99.1
|
|
| NEWS RELEASE
|
6140 Stoneridge Mall Road Suite 590 Pleasanton, CA 94588 925-460-3663 www.coopercos.com | |
| CONTACT: Kim Duncan Vice President, Investor Relations ir@cooperco.com |
THE COOPER COMPANIES APPOINTS WILLIAM KOZY AND COLLEEN JAY TO BOARD OF DIRECTORS
PLEASANTON, Calif., April 4, 2016 –The Cooper Companies, Inc. (NYSE:COO) announced the appointment of Colleen E. Jay and William A. Kozy to its Board of Directors, effective April 1, 2016.
Ms. Jay is the President of the Beauty Specialty Business at Proctor & Gamble, an American multinational consumer goods company. She has held this role since 2015 and is responsible for the business’ skin care, hair care and personal care product business. Prior to taking leadership of the Beauty Specialty Business, Ms. Jay led the Global Retail Hair Care and Color division of Proctor & Gamble from 2012 to 2015 and the Global Female Beauty division from 2010 to 2012. She also served as Vice President & General Manager, Greater China Feminine Care, Personal Cleansing, Oral Care & Entire China Marketing Function from 2006 to 2009, where she was responsible for businesses with a combined value of over $1 billion. She has worked in various positions with Proctor & Gamble since July 1985. Ms. Jay has a bachelor’s degree in Business Administration from Wilfred Laurier University.
From 2012 until his recent retirement, Mr. Kozy served as the Executive Vice President & Chief Operating Officer of Becton, Dickinson and Company, a global medical technology company that is focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, and advancing drug discovery. Prior to taking on the chief operating officer role, Mr. Kozy served as an executive vice president from 2006 through 2012 and in various other senior executive positions with Becton Dickinson since 1988. Mr. Kozy has a bachelor’s degree in English from Kenyon College.
“We are excited to welcome Ms. Jay and Mr. Kozy to the Cooper board of directors,” said A. Thomas Bender, the Chairman of the Board. “They each bring extensive experience in international business operations and we expect them to make valuable contributions to our board.”
About The Cooper Companies
The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified
portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
###